2251 - 2275 of 8100 Results
Title
Year
-
RESTRICTEDTitle: Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 297End Page: 310Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13412Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13412Citation Count: 2
-
RESTRICTEDTitle: Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 311End Page: 325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13415Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13415Citation Count: 2
- An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol2022OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 5
- Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment2022OPENTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 5
-
OPENTitle: GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1016End Page: 1027Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28932Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28932Citation Count: 61
- Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic2022OPENTitle: Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 PandemicJournal Name: Frontiers in Public HealthPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpubh.2021.772805Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpubh.2021.772805/pdfCitation Count: 7
-
RESTRICTEDTitle: Association of Essential Tremor With Novel Risk LociJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 185End Page: 185Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4781Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2787239/jamaneurology_liao_2022_oi_210083_1644604359.06757.pdfCitation Count: 21
-
OPENTitle: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)Journal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 2Start Page: e052032End Page: e052032Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/2/e052032.full.pdfCitation Count: 4
- Competitive Displacement of De Novo Designed HeteroDimers Can Reversibly Control Protein–Protein Interactions and Implement Feedback in Synthetic Circuits2022RESTRICTEDTitle: Competitive Displacement of De Novo Designed HeteroDimers Can Reversibly Control Protein–Protein Interactions and Implement Feedback in Synthetic CircuitsJournal Name: GEN BiotechnologyPublisher: Mary Ann Liebert IncVol: 1Issue #: 1Start Page: 91End Page: 100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/genbio.2021.0011Citation Count: 4
-
OPENTitle: Deep Learning‐Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1064End Page: 1069Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28933Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28933Citation Count: 23
-
RESTRICTEDTitle: Functional neurological disorder and somatic symptom disorder in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 433Issue #:Start Page: 120017End Page: 120017Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120017Citation Count: 12
-
RESTRICTEDTitle: GBA mutations, glucosylceramide and Parkinson's diseaseJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 72Issue #:Start Page: 148End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.conb.2021.11.004Citation Count: 27
- Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level2022OPENTitle: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA levelJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 213End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-021-00999-yBest OA location URL: https://www.nature.com/articles/s41593-021-00999-y.pdfCitation Count: 286
- Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms2022RESTRICTEDTitle: Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanismsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 163Issue #:Start Page: 105580End Page: 105580Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105580Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105580Citation Count: 21
-
RESTRICTEDTitle: New dopaminergic therapies for PD motor complicationsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 204Issue #:Start Page: 108869End Page: 108869Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108869Citation Count: 8
-
RESTRICTEDTitle: Parkinsonism and tremor syndromesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 433Issue #:Start Page: 120018End Page: 120018Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120018Best OA location URL: http://www.jns-journal.com/article/S0022510X21027143/pdfCitation Count: 12
-
RESTRICTEDTitle: PARkinson's: From cellular mechanisms to potential therapeuticsJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 230Issue #:Start Page: 107968End Page: 107968Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107968Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821123Citation Count: 4
- PTEN-induced kinase 1 (PINK1) and Parkin: Unlocking a mitochondrial quality control pathway linked to Parkinson's disease2022RESTRICTEDTitle: PTEN-induced kinase 1 (PINK1) and Parkin: Unlocking a mitochondrial quality control pathway linked to Parkinson's diseaseJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 72Issue #:Start Page: 111End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.conb.2021.09.005Best OA location URL: https://doi.org/10.1016/j.conb.2021.09.005Citation Count: 45
- Rapid global phaseout of animal agriculture has the potential to stabilize greenhouse gas levels for 30 years and offset 68 percent of CO2 emissions this century2022OPENTitle: Rapid global phaseout of animal agriculture has the potential to stabilize greenhouse gas levels for 30 years and offset 68 percent of CO2 emissions this centuryJournal Name: PLOS ClimatePublisher: Public Library of Science (PLoS)Vol: 1Issue #: 2Start Page: e0000010End Page: e0000010Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pclm.0000010Best OA location URL: https://journals.plos.org/climate/article/file?id=10.1371/journal.pclm.0000010&type=printableCitation Count: 98
- Reply to: “Age‐Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK‐PD)”2022OPENTitle: Reply to: “Age‐Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK‐PD)”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 436End Page: 437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28920Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979549Citation Count: 0
-
RESTRICTEDTitle: Rodent models based on endolysosomal genes involved in Parkinson's diseaseJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 72Issue #:Start Page: 55End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.conb.2021.09.004Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/682987/2/Rodent%20models%20based%20on%20endolysosomal%20genes%20involved%20in%20PD_submittedversion.pdfCitation Count: 2
-
RESTRICTEDTitle: Targeting cellular senescence with senotherapeutics: senolytics and senomorphicsJournal Name: The FEBS JournalPublisher: WileyVol: 290Issue #: 5Start Page: 1362End Page: 1383Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/febs.16350Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.16350Citation Count: 160
- The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life2022OPENTitle: The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 291End Page: 301Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28952Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28952Citation Count: 13
-
RESTRICTEDTitle: The potential utility of smell testing to screen for neurodegenerative disordersJournal Name: Expert Review of Molecular DiagnosticsPublisher: Informa UK LimitedVol: 22Issue #: 2Start Page: 139End Page: 148Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737159.2022.2037424Best OA location URL: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76598Citation Count: 1
-
OPENTitle: ThX: a next generation probe for the early detection of amyloid aggregatesJournal Name: Biophysical JournalPublisher: Elsevier BVVol: 121Issue #: 3Start Page: 19aEnd Page: 19aPublication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bpj.2021.11.2608Best OA location URL: https://doi.org/10.1016/j.bpj.2021.11.2608Citation Count: 1